SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by Fulcrum Capital LLC

Fulcrum Capital LLC boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 48,196 shares of the exchange traded fund’s stock after buying an additional 669 shares during the quarter. Fulcrum Capital LLC owned 0.06% of SPDR S&P Biotech ETF worth $4,762,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Fifth Third Bancorp lifted its holdings in SPDR S&P Biotech ETF by 3.4% during the 2nd quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock worth $10,968,000 after buying an additional 3,922 shares in the last quarter. RFG Advisory LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter valued at approximately $219,000. Avantax Advisory Services Inc. increased its position in shares of SPDR S&P Biotech ETF by 17.2% in the 1st quarter. Avantax Advisory Services Inc. now owns 9,619 shares of the exchange traded fund’s stock valued at $913,000 after purchasing an additional 1,415 shares during the last quarter. PFG Investments LLC increased its position in shares of SPDR S&P Biotech ETF by 9.2% in the 2nd quarter. PFG Investments LLC now owns 24,844 shares of the exchange traded fund’s stock valued at $2,303,000 after purchasing an additional 2,097 shares during the last quarter. Finally, Brookstone Capital Management purchased a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter valued at approximately $284,000.

SPDR S&P Biotech ETF Trading Down 1.6 %

Shares of NYSEARCA:XBI opened at $96.67 on Thursday. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The company’s 50 day moving average is $99.16 and its two-hundred day moving average is $94.52. The company has a market cap of $7.37 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.